Pathological evaluation of differentiated thyroid cancer in patients with positive serum thyroglobulin and negative iodine scan
MetadataShow full item record
OBJECTIVE: There is no investigation that emphasizes the pathology of DTC (differentiated thyroid cancer) patients with positive Tg and negative iodine scan. The present study was performed to assess the pathology of these patients. MATERIALS AND METHODS: In this retrospective study, the records of 500 patients with differentiated thyroid cancer between June 2005 and November 2011 were assessed, and those patients who had elevated serum thyroglobulin (Tg) with a negative whole body I-131 scan (Tg+/WBS-) were included in the study. Patients were followed for clinical and pathological findings of thyroid cancer, including type, variant, local invasion and cervical lymph node metastasis, and serumTg,TgAb, and TSH levels. RESULTS: A total of 38 patients, including 31 (81.6%) females and 7 (18.4) males with a mean age of 44.2 ± 15.6 years (range, 14 to 77 yrs) took part in the study. All 38 patients had the papillary type of differentiated thyroid cancer (PCDTC), and none had the follicular type of differentiated thyroid cancer (FCDTC). For the variant type of PTC in 16 patients, it was found that 7 were classic type (43.8%), 7 were follicular type (43.8%), and 2 were tall cell (12.4%) for papillary thyroid cancer. In 22 patients no distinct variant had been reported. CONCLUSIONS: This report demonstrated that all of the 38 patients were PTC (100%), which is different from other previous studies. It may be concluded that the overall pathologic subtypes changes of DTC could mainly be due to the iodine fortification program in various geographic regions. The relationship between DTC pathologic subtypes and frequency of Tg+/WBS- condition was difficult to assess in this work. Therefore, further studies are required to evaluate this issue.
Showing items related by title, author, creator and subject.
A study of the time of hospital discharge of differentiated thyroid cancer patients after receiving iodine-131 for thyroid remnant ablation treatment Azizmohammadi, Z; Tabei, F; Shafiei, B; Babaei, AA; Jukandan, SMQ; Naghshine, R; Javadi, H; Nabipour, I; Assadi, M; Asli, IN (2013)The aim of this study was to measure the radiation exposure rate from differentiated thyroid carcinoma (DTC) patients who had received iodine-131 (131I) treatment, and to evaluate hospital discharge planning in relation ...
Encapsulated Insular Carcinoma of the Thyroid Arising in Graves’ Disease: Report of a Case and Review of the Literature Foroughi, F; Saadat, N; Salehian, MT (2012)Insular carcinoma represents a rather rare form of thyroid cancer. Total encapsulation and history of hyperthyroidism are even extremely rarer events with only a few cases reported in the literature. This article reports ...
99m Tc-MIBI scintigraphy versus 131I whole body scan in the follow-up of patients with differentiated thyroid carcinoma Sh, D (2006)Thyroid cancer is the most common endocrine malignancy. More than 90% of primary thyroid cancers are papillary or follicular types, together termed Differentiated Thyroid Cancers (DTC. The aim of this study was to assess ...